MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
-15.1%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.29B
AUM Growth
-$350M
(-21%)
Cap. Flow
-$14.1M
Cap. Flow
% of AUM
-1.09%
Top 10 Holdings %
Top 10 Hldgs %
26.92%
Holding
2,728
New
402
Increased
996
Reduced
860
Closed
275
Top Buys
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$32.4M |
| 2 |
iShares Short Treasury Bond ETF
SHV
|
+$20.3M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$16.3M |
| 4 |
Vanguard Total Bond Market
BND
|
+$11.2M |
| 5 |
JPMorgan Chase
JPM
|
+$7.28M |
Top Sells
| 1 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$21.2M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$18.9M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$11.7M |
| 4 |
American Water Works
AWK
|
+$7.59M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$7.35M |
Sector Composition
| 1 | Technology | 19.48% |
| 2 | Healthcare | 15.01% |
| 3 | Financials | 10.3% |
| 4 | Consumer Discretionary | 8.01% |
| 5 | Communication Services | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Verrica Pharmaceuticals
VRCA
$49.1M
| $42K | ﹤0.01% |
392
-38
| -9% | -$4.07K |
|
977
VeriSign
VRSN
$26.6B
| $42K | ﹤0.01% |
231
+118
| +104% | +$21.5K |
|
978
Virtus Investment Partners
VRTS
$1.31B
| $42K | ﹤0.01% |
553
+197
| +55% | +$15K |
|
|
RPT
979
Rithm Property Trust Inc.
RPT
$124M
| $42K | ﹤0.01% |
6,700
-21,319
| -76% | -$134K |
|
|
TRHC
980
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $42K | ﹤0.01% |
803
+1
| +0.1% | +$52 |
|
|
PCSB
981
DELISTED
PCSB Financial Corporation
PCSB
| $42K | ﹤0.01% |
2,973
+2,467
| +488% | +$34.9K |
|
|
ACBI
982
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $42K | ﹤0.01% |
3,538
-882
| -20% | -$10.5K |
|
|
TCO
983
DELISTED
Taubman Centers Inc.
TCO
| $42K | ﹤0.01% |
+1,009
| New | +$42K |
|
984
Arista Networks
ANET
$195B
| $41K | ﹤0.01% |
3,296
+2,000
| +154% | +$24.9K |
|
985
ArcBest
ARCB
$1.64B
| $41K | ﹤0.01% |
2,353
+1,808
| +332% | +$31.5K |
|
986
Center Bancorp
CNOB
$1.25B
| $41K | ﹤0.01% |
3,031
-1,272
| -30% | -$17.2K |
|
987
Fresh Del Monte Produce
FDP
$1.69B
| $41K | ﹤0.01% |
1,469
+1,097
| +295% | +$30.6K |
|
988
Plexus
PLXS
$3.74B
| $41K | ﹤0.01% |
759
+702
| +1,232% | +$37.9K |
|
989
SPDR Portfolio Developed World ex-US ETF
SPDW
$29.7B
| $41K | ﹤0.01% |
+1,692
| New | +$41K |
|
|
TRTX
990
TPG RE Finance Trust
TRTX
$749M
| $41K | ﹤0.01% |
7,403
-28,603
| -79% | -$158K |
|
|
RVNC
991
DELISTED
Revance Therapeutics, Inc.
RVNC
| $41K | ﹤0.01% |
2,699
+1,076
| +66% | +$16.3K |
|
992
Ardelyx
ARDX
$1.61B
| $40K | ﹤0.01% |
7,115
+146
| +2% | +$821 |
|
993
C.H. Robinson
CHRW
$15.2B
| $40K | ﹤0.01% |
609
+51
| +9% | +$3.35K |
|
994
Cerence
CRNC
$420M
| $40K | ﹤0.01% |
2,669
+1,809
| +210% | +$27.1K |
|
995
Helen of Troy
HELE
$555M
| $40K | ﹤0.01% |
276
+75
| +37% | +$10.9K |
|
996
Spok Holdings
SPOK
$356M
| $40K | ﹤0.01% |
+3,779
| New | +$40K |
|
|
LTRPA
997
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $40K | ﹤0.01% |
22,169
-21,513
| -49% | -$38.8K |
|
998
Aprea Therapeutics
APRE
$9.2M
| $39K | ﹤0.01% |
+56
| New | +$39K |
|
999
Avient
AVNT
$3.4B
| $39K | ﹤0.01% |
2,039
+20
| +1% | +$383 |
|
1000
Federated Hermes
FHI
$4.11B
| $39K | ﹤0.01% |
2,100
+1,547
| +280% | +$28.7K |
|